Clinical improvement of Long-COVID is associated with reduction in autoantibodies, lipids, and inflammation following therapeutic apheresis
© 2023. The Author(s)..
In the aftermath of the COVID-19 pandemic, we are witnessing an unprecedented wave of post-infectious complications. Most prominently, millions of patients with Long-Covid complain about chronic fatigue and severe post-exertional malaise. Therapeutic apheresis has been suggested as an efficient treatment option for alleviating and mitigating symptoms in this desperate group of patients. However, little is known about the mechanisms and biomarkers correlating with treatment outcomes. Here, we have analyzed in different cohorts of Long-Covid patients specific biomarkers before and after therapeutic apheresis. In patients that reported a significant improvement following two cycles of therapeutic apheresis, there was a significant reduction in neurotransmitter autoantibodies, lipids, and inflammatory markers. Furthermore, we observed a 70% reduction in fibrinogen, and following apheresis, erythrocyte rouleaux formation and fibrin fibers largely disappeared as demonstrated by dark field microscopy. This is the first study demonstrating a pattern of specific biomarkers with clinical symptoms in this patient group. It may therefore form the basis for a more objective monitoring and a clinical score for the treatment of Long-Covid and other postinfectious syndromes.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:28 |
|---|---|
| Enthalten in: |
Molecular psychiatry - 28(2023), 7 vom: 02. Juli, Seite 2872-2877 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Achleitner, Martin [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 01.11.2023 Date Revised 12.12.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1038/s41380-023-02084-1 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM356343863 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM356343863 | ||
| 003 | DE-627 | ||
| 005 | 20231227131233.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/s41380-023-02084-1 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1225.xml |
| 035 | |a (DE-627)NLM356343863 | ||
| 035 | |a (NLM)37131073 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Achleitner, Martin |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Clinical improvement of Long-COVID is associated with reduction in autoantibodies, lipids, and inflammation following therapeutic apheresis |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 01.11.2023 | ||
| 500 | |a Date Revised 12.12.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2023. The Author(s). | ||
| 520 | |a In the aftermath of the COVID-19 pandemic, we are witnessing an unprecedented wave of post-infectious complications. Most prominently, millions of patients with Long-Covid complain about chronic fatigue and severe post-exertional malaise. Therapeutic apheresis has been suggested as an efficient treatment option for alleviating and mitigating symptoms in this desperate group of patients. However, little is known about the mechanisms and biomarkers correlating with treatment outcomes. Here, we have analyzed in different cohorts of Long-Covid patients specific biomarkers before and after therapeutic apheresis. In patients that reported a significant improvement following two cycles of therapeutic apheresis, there was a significant reduction in neurotransmitter autoantibodies, lipids, and inflammatory markers. Furthermore, we observed a 70% reduction in fibrinogen, and following apheresis, erythrocyte rouleaux formation and fibrin fibers largely disappeared as demonstrated by dark field microscopy. This is the first study demonstrating a pattern of specific biomarkers with clinical symptoms in this patient group. It may therefore form the basis for a more objective monitoring and a clinical score for the treatment of Long-Covid and other postinfectious syndromes | ||
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a Lipoproteins, LDL |2 NLM | |
| 650 | 7 | |a Autoantibodies |2 NLM | |
| 650 | 7 | |a Biomarkers |2 NLM | |
| 700 | 1 | |a Steenblock, Charlotte |e verfasserin |4 aut | |
| 700 | 1 | |a Dänhardt, Juliane |e verfasserin |4 aut | |
| 700 | 1 | |a Jarzebska, Natalia |e verfasserin |4 aut | |
| 700 | 1 | |a Kardashi, Romina |e verfasserin |4 aut | |
| 700 | 1 | |a Kanczkowski, Waldemar |e verfasserin |4 aut | |
| 700 | 1 | |a Straube, Richard |e verfasserin |4 aut | |
| 700 | 1 | |a Rodionov, Roman N |e verfasserin |4 aut | |
| 700 | 1 | |a Bornstein, Nitzan |e verfasserin |4 aut | |
| 700 | 1 | |a Tselmin, Sergey |e verfasserin |4 aut | |
| 700 | 1 | |a Kaiser, Frank |e verfasserin |4 aut | |
| 700 | 1 | |a Bucher, Ronald |e verfasserin |4 aut | |
| 700 | 1 | |a Barbir, Mahmoud |e verfasserin |4 aut | |
| 700 | 1 | |a Wong, Ma-Li |e verfasserin |4 aut | |
| 700 | 1 | |a Voit-Bak, Karin |e verfasserin |4 aut | |
| 700 | 1 | |a Licinio, Julio |e verfasserin |4 aut | |
| 700 | 1 | |a Bornstein, Stefan R |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Molecular psychiatry |d 1997 |g 28(2023), 7 vom: 02. Juli, Seite 2872-2877 |w (DE-627)NLM09062694X |x 1476-5578 |7 nnns |
| 773 | 1 | 8 | |g volume:28 |g year:2023 |g number:7 |g day:02 |g month:07 |g pages:2872-2877 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1038/s41380-023-02084-1 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 28 |j 2023 |e 7 |b 02 |c 07 |h 2872-2877 | ||